Get startedLog in
    Picture of Flerie AB logo

    FLERIE — Flerie AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Brief: Microbiotica Reports Positive Phase 1B Data For MB310

    Picture of Flerie AB logoFlerie AB
    11/02/2026 10:41
    Feb 11 (Reuters) - Flerie AB FLERIE.ST:

FLERIE'S PORTFOLIO COMPANY MICROBIOTICA REPORTS POSITIVE PHASE 1B DATA FOR MB310 IN PATIENTS WITH ULCERATIVE COLITIS

MICROBIOTICA'S DRUG CANDIDATE MB310, A PRECISION MICROBIOME MEDICINE, MET ITS PRIMARY AND SECONDARY OBJECTIVES

DRUG CANDIDATE EXHIBITED A FAVOURABLE SAFETY PROFILE

Source text: ID:nMFN8QZ3s4

Further company coverage: FLERIE.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Flerie AB

    See all news